New horizons in the treatment of osteosarcoma

PS Meltzer, LJ Helman - New England Journal of Medicine, 2021 - Mass Medical Soc
Osteosarcoma Osteosarcoma, which is most common in people 10 to 30 years of age, is
generally treated with resection and adjuvant chemotherapy. Detection of gene rearrangements…

Mechanisms of sarcoma development

LJ Helman, P Meltzer - Nature Reviews Cancer, 2003 - nature.com
Sarcomas are a rare and diverse group of tumours that are derived from connective tissues,
including bone, muscle and cartilage. Although there are instances of hereditary …

Rhabdomyosarcoma: an overview

R Dagher, L Helman - The oncologist, 1999 - academic.oup.com
Rhabdomyosarcoma (RMS) is a malignant tumor of mesenchymal origin thought to arise
from cells committed to a skeletal muscle lineage. With approximately 250 cases diagnosed …

[HTML][HTML] Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

…, JR Wunderlich, AV Nahvi, LJ Helman… - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
Purpose Adoptive immunotherapy using tumor-infiltrating lymphocytes represents an
effective cancer treatment for patients with metastatic melanoma. The NY-ESO-1 cancer/testis …

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism

X Wan, B Harkavy, N Shen, P Grohar, LJ Helman - Oncogene, 2007 - nature.com
Rapamycin and several analogs, such as CCI-779 and RAD001, are currently undergoing
clinical evaluation as anticancer agents. In this study, we show that inhibition of mammalian …

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

…, C Yeung, R Gorlick, SM Hewitt, LJ Helman - Nature medicine, 2004 - nature.com
Metastatic cancers, once established, are the primary cause of mortality associated with
cancer. Previously, we used a genomic approach to identify metastasis-associated genes in …

Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations

…, JA Fletcher, L Helman… - Proceedings of the …, 2011 - National Acad Sciences
Carney-Stratakis syndrome, an inherited condition predisposing affected individuals to
gastrointestinal stromal tumor (GIST) and paraganglioma, is caused by germline mutations in …

Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators

Y Yu, J Khan, C Khanna, L Helman, PS Meltzer… - Nature medicine, 2004 - nature.com
Patients presenting with metastatic rhabdomyosarcoma (RMS), the most common soft-tissue
sarcoma in children, have a very poor clinical prognosis. This is due, in large part, to our …

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

…, JA Berzofsky, CS Carter, EJ Read, LJ Helman… - Nature medicine, 2005 - nature.com
CD4 + CD25 + regulatory T (T reg ) cells have a crucial role in maintaining immune tolerance.
Mice and humans born lacking T reg cells develop severe autoimmune disease 1 , 2 , and …

[HTML][HTML] Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies

…, VL Giranda, G Gordon, L Helman… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
Purpose We conducted the first phase 0 clinical trial in oncology of a therapeutic agent
under the Exploratory Investigational New Drug Guidance of the US Food and Drug …